BTA 0.00% 57.0¢ biota holdings limited

Ann: Phase III prophylaxis trial for CS-8958 , page-43

  1. 2,630 Posts.
    lightbulb Created with Sketch. 4
    Of course Relenza's prophylactic properties put it on a collision course with GSK's vaccination interests - so it went nowhere.
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.